Qianhong Pharmaceutical: Shareholder Zhao Gang terminates the reduction plan ahead of schedule.

Qianhong Pharmaceutical announcement: Shareholder Zhao Gang, who holds more than 5% of shares, and his concerted action person originally planned to reduce their holdings by no more than 20.9 million shares, accounting for 1.6331% of the total share capital, through centralized bidding or block trading within 3 months after 15 trading days following disclosure. As of November 21, 2025, they have already reduced their holdings by 6.0476 million shares through centralized bidding, accounting for 0.4725% of the total share capital, with an average price of 8.5 yuan per share, and the reduced price range is between 8.26 yuan per share and 8.62 yuan per share. The above-mentioned shareholders have decided to terminate the reduction plan in advance and currently hold a total of 81.8654 million shares, accounting for 6.3967% of the total share capital.